The report provides market dynamics and trends related to the bioprocess validation market. In addition, it presents estimations and forecast of the market. Bioprocess validation involves a series of activities taking place over the entire production cycle of a bio-product. An important part of bioprocess validation requires the evaluation of active pharmaceutical ingredients (APIs) and possible contaminants such as mycoplasma, bacteria, endotoxin, and others during the development and manufacture processes of human and animal drugs, or other biological products.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW 

CHAPTER 4: BIOPROCESS VALIDATION, BY TEST TYPE

CHAPTER 5: BIOPROCESS VALIDATION, BY PROCESS COMPONENT 

CHAPTER 6: BIOPROCESS VALIDATION, BY END USER

CHAPTER 7: GLOBAL BIOPROCESS VALIDATION MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES .